UK markets open in 7 hours 7 minutes
NIKKEI 225
38,787.38 -132.92 (-0.34%) HANG SENG
19,553.61 +177.11 (+0.91%) CRUDE OIL
79.84 -0.22 (-0.27%) GOLD FUTURES
2,423.30 +5.90 (+0.24%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,120.72 -554.53 (-1.05%)
HCW Biologics Inc. (HCWB)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 41.61M |
| Enterprise value | 45.92M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.16 |
| Price/book (mrq) | 4.76 |
| Enterprise value/revenue | 11.69 |
| Enterprise value/EBITDA | -3.63 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -30.99% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 2.3200 |
| 52-week low 3 | 0.9100 |
| 50-day moving average 3 | 1.5003 |
| 200-day moving average 3 | 1.5173 |
Share statistics
| Avg vol (3-month) 3 | 20.02k |
| Avg vol (10-day) 3 | 34.63k |
| Shares outstanding 5 | 37.82M |
| Implied shares outstanding 6 | 39.89M |
| Float 8 | 17.85M |
| % held by insiders 1 | 52.30% |
| % held by institutions 1 | 2.91% |
| Shares short (30 Apr 2024) 4 | 8.62k |
| Short ratio (30 Apr 2024) 4 | 1.17 |
| Short % of float (30 Apr 2024) 4 | 0.04% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.02% |
| Shares short (prior month 28 Mar 2024) 4 | 15.87k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -665.09% |
Management effectiveness
| Return on assets (ttm) | -47.07% |
| Return on equity (ttm) | -132.46% |
Income statement
| Revenue (ttm) | 3.93M |
| Revenue per share (ttm) | 0.11 |
| Quarterly revenue growth (yoy) | 2,590.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -27.1M |
| Net income avi to common (ttm) | -27.39M |
| Diluted EPS (ttm) | -0.7600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.08M |
| Total cash per share (mrq) | 0.11 |
| Total debt (mrq) | 8.27M |
| Total debt/equity (mrq) | 94.67% |
| Current ratio (mrq) | 0.46 |
| Book value per share (mrq) | 0.23 |
Cash flow statement
| Operating cash flow (ttm) | -22.48M |
| Levered free cash flow (ttm) | -12.79M |
© 2024 Yahoo. All rights reserved.